Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-severe Pain Following Abdominal Surgery
Clinical trial NCT06904248 · COMPLETED
Trial details
- NCT number
- NCT06904248
- Sponsor
- Yangtze River Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-29
- Primary completion
- 2024-11-20
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.